Ingredient(s): Each capsule contains: 0.5 mg trandolapril
Indications: Mild or moderate hypertension. Left ventricular
dysfunction after myocardial infarction. It has been demonstrated that
trandolapril improves survival following myocardial infarction in patients
with left ventricular dysfunction (ejection fraction £
35 percent), with or without symptoms of heart failure and/or with or
without residual ischemia. Long-term treatment with trandolapril
significantly reduces the overall cardiovascular mortality. It significantly
decreases the risk of sudden death and the occurrence of severe or resistant
heart failure.
Ingredient(s): Each capsule contains: 2 mg trandolapril
Indications: Mild or moderate hypertension. Left ventricular
dysfunction after myocardial infarction. It has been demonstrated that
trandolapril improves survival following myocardial infarction in patients
with left ventricular dysfunction (ejection fraction £
35 percent), with or without symptoms of heart failure and/or with or
without residual ischemia. Long-term treatment with trandolapril
significantly reduces the overall cardiovascular mortality. It significantly
decreases the risk of sudden death and the occurrence of severe or resistant
heart failure.